ICIs primarily counteract the immunosuppressive effects of tumor cells on T cells by blocking the interaction between immunosuppressive regulatory proteins on the cell surface, such as CTLA-4, PD-1, and PD-L1. The gene discussed is CTLA4; the disease is neoplasm.